VR Logo

Aurobindo Pharma: Board Meeting Intimation for Intimation Of Board Meeting.


AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2020 inter alia to consider and approve We hereby inform pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that a Meeting of the Board of Directors of the Company will be held on Wednesday 12th August 2020 to consider and approve inter alia the following:
1. Standalone & Consolidated Unaudited Financial Results of the Company for the first quarter ended June 30 2020 and
2. Payment of Interim Dividend if any for the financial year 2020-21.
Further to our letter dated June 29 2020 informing the closure of Trading Window of the Company from July 1 2020 until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the first quarter ended June 30 2020 we inform you that the Trading Window will remain closed up to August 14 2020 and shall be re-opened on August 15 2020.

Click here to view PDF